Assessing glycemic and weight-lowering potential of oral semaglutide in type 2 diabetes compared to other GLP-1 receptor agonists in Indian context

被引：0
|
作者：
Singh, Awadhesh Kumar [1 ,2 ,3 ]
Chawla, Rajeev [4 ]
机构：
[1] GD Hosp & Diabet Inst, Kolkata 700013, West Bengal, India
[2] Horizon Multispecial Hosp, Kolkata, West Bengal, India
[3] Sun Valley Hosp & Diabet Res Ctr, Gauhati, Assam, India
[4] North Delhi Diabet Ctr, New Delhi, India
来源：
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES | 2024年 / 44卷 / 02期
关键词：
ONCE-WEEKLY SEMAGLUTIDE; OPEN-LABEL; PHASE; 3A; CARDIOVASCULAR OUTCOMES; JAPANESE PATIENTS; ADD-ON; EFFICACY; SAFETY; DULAGLUTIDE; METFORMIN;
D O I：
10.1007/s13410-024-01337-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：211 / 215
页数：5
相关论文
共 50 条
  • [1] The development of oral semaglutide, an oral GLP-1 analog, for the treatment of type 2 diabetes
    Rasmussen, Mads Frederik
    DIABETOLOGY INTERNATIONAL, 2020, 11 (02) : 76 - 86
  • [2] Semaglutide GLP-1 receptor agonist Treatment of type 2 diabetes
    Chudleigh, R.
    Bain, S. C.
    DRUGS OF THE FUTURE, 2017, 42 (08) : 479 - 487
  • [3] Assessing the therapeutic and toxicological profile of novel GLP-1 receptor agonists for type 2 diabetes
    Kukova, Lidiya
    Munir, Kashif M.
    Sayeed, Ahmed
    Davis, Stephen N.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (10) : 939 - 952
  • [4] GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art
    Granata, Antonio
    Maccarrone, Rosario
    Anzaldi, Massimiliano
    Leonardi, Giuseppe
    Pesce, Francesco
    Amico, Francesco
    Gesualdo, Loreto
    Corrao, Salvatore
    CLINICAL KIDNEY JOURNAL, 2022, 15 (09) : 1657 - 1665
  • [5] GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes
    Isabel del Olmo-Garcia, Maria
    Francisco Merino-Torres, Juan
    JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [6] Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes
    Trujillo, Jennifer
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 : 43 - 60
  • [7] The efficacy and safety of oral semaglutide for glycaemic management in adults with type 2 diabetes compared to subcutaneous semaglutide, placebo, and other GLP-1 RA comparators: A systematic review and network meta-analysis
    Alhindi, Yousef
    Avery, Amanda
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2022, 28
  • [8] GLP-1 receptor agonists in the treatment of type 2 diabetes: role and clinical experience to date
    Brunton, Stephen A.
    Wysham, Carol H.
    POSTGRADUATE MEDICINE, 2020, 132 : 3 - 14
  • [9] Systematic review of the efficacy and safety of GLP-1 receptor agonists in the treatment of patients with type 2 diabetes mellitus
    Petrova, Lora
    Andreevska, Kalina
    Parvova, Iva
    Petkova, Valentina
    PHARMACIA, 2024, 71 : 1 - 17
  • [10] GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes A Direct Comparison of Glycemic Control
    Seufert, J.
    DIABETOLOGIE UND STOFFWECHSEL, 2015, 10 (03) : 141 - 147
12345